| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.8M | +14.4% |
| Cost of Revenue | $19.5M | +15.4% |
| Gross Profit | $64.3M | +14.2% |
| R&D Expense | $3.0M | +5.1% |
| SG&A Expense | $17.8M | +11.6% |
| Operating Income | $26.1M | +19.0% |
| Pre-tax Income | $28.4M | +16.8% |
| Income Tax | $5.9M | +16.7% |
| Net Income | $22.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.2M | -2.1% |
| Accounts Receivable | $13.7M | +29.5% |
| Inventory | $11.6M | +11.7% |
| Current Assets | $81.2M | +7.9% |
| Total Assets | $108.8M | +10.6% |
| Current Liabilities | $10.2M | +19.6% |
| Total Liabilities | $14.2M | +23.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.9M | -2.6% |
| Capital Expenditures | $7.8M | -3.0% |
| Investing Cash Flow | -$8.4M | +4.5% |
| Financing Cash Flow | -$17.6M | -22.8% |
| Free Cash Flow | $17.2M | -2.5% |
| +16.9% |
| EPS (Basic) | $1.77 | +16.4% |
| EPS (Diluted) | $1.75 | +16.7% |
| Stockholders' Equity |
| $94.6M |
| +9.0% |